[1] Gonzalez-Franquesa A, Patti ME. Insulin resistance and mitochondrial dysfunction. Adv Exp Med Biol, 2017; 982, 465−520. doi:  DOI:10.1007/978-3-319-55330-6_25
[2] Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol, 2014; 24, R453−62. doi:  10.1016/j.cub.2014.03.034
[3] Koyama Y, Brenner DA. Liver inflammation and fibrosis. J Clin Invest, 2017; 127, 55−64. doi:  10.1172/JCI88881
[4] Lee JH, Budanov AV, Park EJ, et al. Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science, 2010; 327, 1223−8. doi:  10.1126/science.1182228
[5] Lee JH, Budanov AV, Talukdar S, et al. Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3. Cell Metab, 2012; 16, 311−21. doi:  10.1016/j.cmet.2012.08.004
[6] Liang FX, Kume S, Koya D. SIRT1 and insulin resistance. Nat Rev Endocrinol, 2009; 5, 367−73. doi:  10.1038/nrendo.2009.101
[7] Goodpaster BH. Mitochondrial deficiency is associated with insulin resistance. Diabetes, 2013; 62, 1032−5. doi:  10.2337/db12-1612
[8] Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med, 2011; 50, 567−75. doi:  10.1016/j.freeradbiomed.2010.12.006
[9] Singh V, Ubaid S. Role of Silent Information Regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation, 2020; 43, 1589−98. doi:  10.1007/s10753-020-01242-9
[10] Purushotham A, Schug TT, Xu Q, et al. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab, 2009; 9, 327−38. doi:  10.1016/j.cmet.2009.02.006